50 related articles for article (PubMed ID: 23384965)
21. Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1.
Miyagi MY; Seelaender M; Castoldi A; de Almeida DC; Bacurau AV; Andrade-Oliveira V; Enjiu LM; Pisciottano M; Hayashida CY; Hiyane MI; Brum PC; Camara NO; Amano MT
PLoS One; 2014; 9(10):e108543. PubMed ID: 25272046
[TBL] [Abstract][Full Text] [Related]
22. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence.
Sahu BD; Kalvala AK; Koneru M; Mahesh Kumar J; Kuncha M; Rachamalla SS; Sistla R
PLoS One; 2014; 9(9):e105070. PubMed ID: 25184746
[TBL] [Abstract][Full Text] [Related]
23. Tempol protects human lymphocytes from genotoxicity induced by cisplatin.
Khabour OF; Alzoubi KH; Mfady DS; Alasseiri M; Hasheesh TF
Int J Clin Exp Med; 2014; 7(4):982-8. PubMed ID: 24955171
[TBL] [Abstract][Full Text] [Related]
24. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury.
Chen J; Shetty S; Zhang P; Gao R; Hu Y; Wang S; Li Z; Fu J
Toxicol Appl Pharmacol; 2014 Jun; 277(2):118-23. PubMed ID: 24709673
[TBL] [Abstract][Full Text] [Related]
25. Capsaicin ameliorates cisplatin-induced renal injury through induction of heme oxygenase-1.
Jung SH; Kim HJ; Oh GS; Shen A; Lee S; Choe SK; Park R; So HS
Mol Cells; 2014 Mar; 37(3):234-40. PubMed ID: 24642709
[TBL] [Abstract][Full Text] [Related]
26. An extract of Rhodobacter sphaeroides reduces cisplatin-induced nephrotoxicity in mice.
Chang WW; Liu JJ; Liu CF; Liu WS; Lim YP; Cheng YJ; Lee CH
Toxins (Basel); 2013 Nov; 5(12):2353-65. PubMed ID: 24335753
[TBL] [Abstract][Full Text] [Related]
27. Targeting Nrf2 in Protection Against Renal Disease.
Guerrero-Hue M; Farre-Alins V; Palomino-Antolin A; Parada E; Rubio-Navarro A; Egido J; Egea J; Moreno JA
Curr Med Chem; 2017; 24(33):3583-3605. PubMed ID: 28494744
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 deficiency accelerates cisplatin-induced acute renal failure but not systemic injury.
Mitazaki S; Kato N; Suto M; Hiraiwa K; Abe S
Toxicology; 2009 Nov; 265(3):115-21. PubMed ID: 19833167
[TBL] [Abstract][Full Text] [Related]
29. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
[TBL] [Abstract][Full Text] [Related]
30. The dimethylthiourea-induced attenuation of cisplatin nephrotoxicity is associated with the augmented induction of heat shock proteins.
Tsuji T; Kato A; Yasuda H; Miyaji T; Luo J; Sakao Y; Ito H; Fujigaki Y; Hishida A
Toxicol Appl Pharmacol; 2009 Jan; 234(2):202-8. PubMed ID: 18992762
[TBL] [Abstract][Full Text] [Related]
31. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
32. Hyperin inhibits nuclear factor kappa B and activates nuclear factor E2-related factor-2 signaling pathways in cisplatin-induced acute kidney injury in mice.
Chao CS; Tsai CS; Chang YP; Chen JM; Chin HK; Yang SC
Int Immunopharmacol; 2016 Nov; 40():517-523. PubMed ID: 27764742
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 modulates oxidative stress produced during the development of cisplatin nephrotoxicity.
Mitazaki S; Hashimoto M; Matsuhashi Y; Honma S; Suto M; Kato N; Nakagawasai O; Tan-No K; Hiraiwa K; Yoshida M; Abe S
Life Sci; 2013 Apr; 92(12):694-700. PubMed ID: 23384965
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment.
Sheikh-Hamad D; Timmins K; Jalali Z
J Am Soc Nephrol; 1997 Oct; 8(10):1640-4. PubMed ID: 9335396
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
